<?xml version="1.0" encoding="UTF-8"?>
<p id="para1900">Acute hepatitis A virus (HAV) and hepatitis E virus (HEV) accounted for 4·7% and 15·4% of all deaths due to acute hepatitis in mainland China in 2015 (
 <xref rid="tbl2" ref-type="table">table 2</xref>).
 <xref rid="bib1" ref-type="bibr">
  <sup>1</sup>
 </xref> As in other low-income and middle-income countries, a relatively high seroprevalence of anti-HAV antibodies compared with high-income countries is reported in China.
 <xref rid="bib113" ref-type="bibr">
  <sup>113</sup>
 </xref> The seroprevalence of anti-HAV has been reported as 51·6% in blood donors with increased alanine aminotransferase concentrations, 41·4% in blood donors without such an increase,
 <xref rid="bib113" ref-type="bibr">
  <sup>113</sup>
 </xref> and 52·9% in a population aged up to 30 years in Shanghai.
 <xref rid="bib114" ref-type="bibr">
  <sup>114</sup>
 </xref> With anti-HAV IgM prevalence of 0·08% in donors of source plasma,
 <xref rid="bib115" ref-type="bibr">
  <sup>115</sup>
 </xref> transmission of HAV by blood transfusion occurs very rarely. Insufficient food and water hygiene as well as hand washing could be responsible for local outbreaks.
 <xref rid="bib116" ref-type="bibr">
  <sup>116</sup>
 </xref>
</p>
